Translational Aspects of 3D and 4D Printing and Bioprinting
Advanced Healthcare Materials · 2024-10 · 13 (27)
DOI: 10.1002/adhm.202400463 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.07.2024. Verfasst von Scott Taylor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Poly-Med, Inc., Anderson, SC 29625, USA. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Bioprinting, Tissue Engineering. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Henry Ford Health, Estonian Research Council.
Abstract (Originalsprache)
Three‐dimensional (3D) printed medical devices include orthopedic and craniofacial implants, surgical tools, and external prosthetics that have been directly used in patients. While the advances of additive manufacturing techniques in the production of medical devices have been on the rise, clinical translation of living cellular constructs face significant limitations in terms of regulatory affairs, process technology, and materials development. In this perspective, the current status‐quo of 3D and four‐dimensional (4D) (bio)printing is summarized, current advancements are discussed and the challenges that need to be addressed for improved industrial translation and clinical applications of bioprinting are highlighted. It is focused on a multidisciplinary approach in discussing the key translational considerations, from the perspective of industry, regulatory bodies, funding strategies, and future directions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Poly-Med, Inc., Anderson, SC 29625, USA.
- Ricoh 3D for Healthcare, Ricoh USA, Winston-Salem, NC 27101, USA.
- Department of Otolaryngology, Henry Ford Heath, Detroit, MI 48322, USA.
- Institute for Quantitative Health Science & Engineering and Department of Engineering, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
- College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.
ORCID-Profile: Ashley V Makela, Nureddin Ashammakhi
Förderung
- NIH HHS
- Henry Ford Health
- Estonian Research Council
- American Heart Association
- Michigan Translational Research and Commercialization Innovation Hub for AgBio
- Department of Surgery
- NCATS NIH HHS
- National Institutes of Health
Zitieren
APA
Taylor, S., Mueller, E., Jones, L. R., Makela, A. V., & Ashammakhi, N. (2024). Translational Aspects of 3D and 4D Printing and Bioprinting. Advanced Healthcare Materials, 13(27). https://doi.org/10.1002/adhm.202400463
Vancouver
Taylor S, Mueller E, Jones LR, Makela AV, Ashammakhi N. Translational Aspects of 3D and 4D Printing and Bioprinting. Advanced Healthcare Materials. 2024;13(27). doi:10.1002/adhm.202400463
BibTeX
@article{Taylor2024,
author = {Taylor, Scott and Mueller, Eva and Jones, Lamont R and Makela, Ashley V and Ashammakhi, Nureddin},
title = {Translational Aspects of 3D and 4D Printing and Bioprinting},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {27},
doi = {10.1002/adhm.202400463}
}
EUVIMED